Insights was established in 1996 as an independent clinical trial
center specializing in Phase II, III, and IV psychopharmacological
research. The mission
of Clinical Insights is to become the gold standard in psychopharmacological
clinical trials. Clinical Insights is a site
in the NIMH CATIE / Schizophrenia Trials Network.
Principal Investigator, Lawrence W. Adler, MD, CPI, has participated
in the conduct of numerous clinical trials in psychiatric disorders
since 1987. We have conducted clinical trials in a variety
of psychiatric areas including depression, bipolar disorder, anxiety
disorders, panic disorder, post-traumatic stress disorder (PTSD),
obsessive-compulsive disorder (OCD), psychosis, schizophrenia,
tardive dyskinesia, Alzheimer's disease, dementia, premenstrual
dysphoric disorder (PMDD), migraine, and alcohol dependence.
who qualify for research studies receive the following at no cost
to the patient or the patient's insurance company:
Insights accepts referrals from any source.
Transportation will be provided for patients who require
| about us | principal
investigator | clinical trials
| interest form | directions